Skip to content

    MEDIFAST (MED) stock price & financials

    View MED earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance14.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $140.16M
    $119.00M
    $115.73M
    $105.56M
    $89.41M
    -36.2%
    $75.10M
    -36.9%
    $76.04M
    -34.3%
    $76.38M
    -27.6%
    Weakening
    Operating Profit
    $2.11M
    $708.0K
    -$1.26M
    -$1.07M
    -$4.08M
    -293.8%
    -$7.80M
    -1202.3%
    -$3.29M
    -161.1%
    -$4.33M
    -305.9%
    Weakening
    Net Profit
    $1.13M
    $800.0K
    -$772.0K
    $2.48M
    -$2.26M
    -300.3%
    -$18.12M
    -2364.9%
    -$2.12M
    -174.9%
    -$3.10M
    -225.0%
    Weakening
    EPS
    $0.10
    $-0.07
    $0.23
    $-0.21
    -310.0%
    $-0.19
    -171.4%
    $-0.28
    -221.7%
    Weakening
    Other Income
    -$528.0K
    $566.0K
    $1.79M
    $3.94M
    $1.42M
    $1.42M
    +151.1%
    $1.35M
    -24.3%
    $1.34M
    -66.1%
    Strengthening
    Interest
    Depreciation
    Profit before Tax
    $1.58M
    $1.27M
    $526.0K
    $2.88M
    -$2.66M
    -268.4%
    -$6.38M
    -601.0%
    -$1.94M
    -469.0%
    -$2.99M
    -204.0%
    Weakening
    MarginsOPM
    1.5%
    0.6%
    -1.1%
    -1.0%
    -4.6%
    -404.0%
    -10.4%
    -1861.0%
    -4.3%
    -297.2%
    -5.7%
    -460.4%
    Weakening
    Tax
    28.4%
    37.2%
    246.8%
    13.7%
    14.9%
    -47.6%
    -183.9%
    -594.1%
    -9.3%
    -103.8%
    -3.6%
    -126.5%
    Weakening
    ReturnsROIC
    0.7%
    0.5%
    -0.5%
    1.6%
    -1.5%
    -300.3%
    -11.8%
    -2364.9%
    -1.4%
    -174.9%
    -2.0%
    -225.0%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$81.36M$76.97M$163.72M$104.18M$87.69M$94.44M$90.93M$89.30M$71.91M
    Short-Term Investments
    Total Current Assets$145.52M$154.15M$234.31M$306.87M$222.78M$224.03M$214.40M$201.68M$202.03M
    Net PP&E$19.75M$38.84M$38.14M$80.59M$75.64M$67.11M$48.68M$38.46M$52.29M
    Goodwill
    Intangibles
    Total Assets$169.43M$194.65M$276.08M$398.33M$316.21M$309.91M$284.21M$247.97M$260.40M
    LiabilitiesTotal Current Liabilities$60.32M$79.39M$111.35M$169.83M$140.89M$92.30M$64.16M$42.96M$41.56M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$10.43M$7.49M$26.02M$20.27M$16.13M$9.94M$6.09M$22.46M
    Total Liabilities$60.32M$89.82M$118.84M$195.85M$161.17M$108.43M$74.10M$49.05M$64.02M
    EquityCommon Stock & APIC$12.0K$12.0K$12.0K$12.0K$11.0K$11.0K$11.0K$11.0K$11.0K
    Retained Earnings$131.34M$168.79M$154.35M$190.33M$139.85M$174.65M$176.78M$158.27M$153.05M
    Total Equity$109.11M$104.83M$157.25M$202.47M$155.04M$201.48M$210.11M$198.92M$196.38M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$60.82M$84.26M$145.20M$94.55M$194.57M$147.66M$24.48M$6.86M$8.79M
    Cash from Investing-$1.20M-$6.33M-$1.28M-$29.06M-$11.41M-$61.05M-$26.52M-$7.93M-$37.60M
    Cash from Financing-$53.33M-$82.32M-$57.14M-$125.13M-$199.58M-$79.79M-$1.51M-$564.0K-$983.0K
    SummaryCapital Expenditure-$4.94M-$10.06M-$5.89M-$34.21M-$16.68M-$6.48M-$7.45M-$5.61M-$4.78M
    Free Cash Flow$55.88M$74.20M$139.31M$60.34M$177.89M$141.17M$17.02M$1.25M$4.01M
    FCF Margin11.2%10.4%14.9%4.0%11.1%13.2%2.8%0.3%1.3%

    Ratios